These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 593121)

  • 1. [Duration of effects of isosorbide dinitrate retard in coronary disease].
    Raab C; Schindler J; Rahlfs VW
    Med Welt; 1977 Nov; 28(44):1807-9. PubMed ID: 593121
    [No Abstract]   [Full Text] [Related]  

  • 2. [Isosorbide dinitrate in coronary heart disease. Effects of a delayed-action preparation during acute load and in chronic use].
    Westermann KW; Eggert R; Kugler G; Priester G
    Med Klin; 1975 Aug; 70(35):1375-9. PubMed ID: 1177792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of nitro-retard preparations during rest and ergometric exercise in patients with coronary heart disease].
    Boutefeu JM; Righetti A; Rutishauser W
    Med Welt; 1980 Aug; 31(35):1251-4. PubMed ID: 7421560
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparison of the efficacy and duration of action of 2 isosorbide dinitrate preparations].
    Magelli C; Marzocchi A; Ferretti RM; Bassein L; Magnani B
    Cardiologia; 1982; 27(6):609-14. PubMed ID: 6892440
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparison of the effects of molsidomine retard and isosorbide dinitrate retard in patients with stable angina pectoris using an ergometry test].
    Rotrekl P; Vlasínová J; Manousek J; Semrád B; Rysavý F; Lupínek Z; Meluzín J; Vlasicová I; Pirochtová I; Bocek O
    Vnitr Lek; 1993 Sep; 39(9):856-64. PubMed ID: 8212639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of dinitrate isosorbide retard forms in ischemic heart disease patients with stable effort angina].
    Lupanov VP; Alekseeva IA; Vasil'eva NN; Komar OA; Romasiuk SS; Naumov VG
    Ter Arkh; 2000; 72(9):33-6. PubMed ID: 11076413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Iso Mack Retard 40 mg. Coronary drug for long term therapy and prophylaxis in coronary circulation disorders (angina pectoris)].
    Wien Klin Wochenschr; 1980 Oct; 92(19):695-6. PubMed ID: 7467343
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma levels of isosorbide dinitrate and the isosorbide mononitrates after increasing doses of a retard preparation of isosorbide dinitrate.
    Bogaert MG; Rosseel MT
    Nouv Presse Med; 1980 Sep; 9(34 Suppl):2424-7. PubMed ID: 7422532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of antianginal efficacy of long-acting sustained release isosorbide dinitrate in comparison with short-acting isosorbide dinitrate.
    Rao YV; Reddy KS; Wasir HS
    Indian Heart J; 1991; 43(2):97-100. PubMed ID: 1752623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New drug forms of isosorbide dinitrate: the problem of an objective evaluation in patients with ischemic heart disease].
    Martsevich SIu; Metelitsa VI; Kozyreva MP; Blagodatskikh SV; Simkhaev LS; Piotrovskiĭ VK
    Farmakol Toksikol; 1991; 54(3):53-6. PubMed ID: 1915825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of combination therapy (isosorbide dinitrate and molsidomine) on the incidence of angina pectoris in patients with coronary heart disease].
    Ciopor M; Fischer A; Turina J; Hess OM
    Praxis (Bern 1994); 1997 Nov; 86(47):1849-53. PubMed ID: 9480502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of the effects of depot isosorbide dinitrate (Isoket Retard 120) and diltiazem in patients with exertional angina pectoris].
    Meluzín J; Lupínek Z; Lupínková Z
    Vnitr Lek; 1990 Feb; 36(2):134-40. PubMed ID: 2186569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of the exercise test for determining the optimal dose of prolonged-action nitrates in patients with angina pectoris].
    Martsevich SIu; Vygodin VA; Metelitsa VI
    Ter Arkh; 1981; 53(12):22-6. PubMed ID: 7347239
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of angina pectoris with beta-receptor blockaders a slow-releasing isosorbide dinitrate preparation].
    Kappenberger L; Fellmann H; Nager F
    Schweiz Med Wochenschr; 1973 Dec; 103(50):1789-92. PubMed ID: 4149035
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of antianginal efficacy of sustained release isosorbide dinitrate with short-acting isosorbide dinitrate.
    Joseph G
    Indian Heart J; 1991; 43(6):477. PubMed ID: 1823901
    [No Abstract]   [Full Text] [Related]  

  • 16. [Dinitrosorbilong--a new Soviet anti-angina preparation. Its comparative pharmacodynamic, pharmacokinetic and clinical study].
    Metelitsa VI; Martsevich SIu; Piotrovskiĭ VK; Blagodatskikh SV; Riabokon' OS
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):20-4. PubMed ID: 3099808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Possibilities of potentiating the antianginal action of nitrates by methionine in patients with stable effort angina pectoris].
    Martsevich SIu; Kozyreva MP; Metelitsa VI
    Kardiologiia; 1991 Aug; 31(8):33-6. PubMed ID: 1795468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitrate tolerance.
    Parker JO
    Herz; 1984 Jun; 9(3):137-45. PubMed ID: 6430767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of sorbonite on exercise tolerance in stable angina pectoris].
    Juszczyk Z
    Pol Tyg Lek; 1982 May; 37(11):301-4. PubMed ID: 7122293
    [No Abstract]   [Full Text] [Related]  

  • 20. Sustained hemodynamic and antianginal effects of high dose oral isosorbide dinitrate.
    Aronow S
    Nouv Presse Med; 1980 Sep; 9(34 Suppl):2483-6. PubMed ID: 7422537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.